|
| |
pharmion.com Pages on BioPortfolio:
BioPortfolio - Pharmion
Pharmion - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/8302-Pharmion.html...
|
Biotechnology News Leukemia Lymphocytic Acute L2 apremilast ...
Current Search: leukemia: 1829, lymphocytic: 56, acute: 497, l2: 4, apremilast: 2, pharmion: 23, vidaza: 48, 2290: 3, revlimid: 85, psor: 2 ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - pharmion.com
pharmion.com - BioPortfolio. ... Pharmion - Entry on Bioportfolio's Biocorporate Database. http://www.bioportfolio.com/biocorporate/8302-Pharmion.html. ...
http://www.bioportfolio.com/search/pharmion.com.html...
|
Biotechnology News multiple sclerosis pharmion. vidaza. revlimid ...
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - pharmion corp
pharmion corp - BioPortfolio. ... Matching: vidaza thalomid pharmion revlimid celg, Find similar documents . ...
http://www.bioportfolio.com/search/pharmion_corp.html...
|
Biotechnology News Myelodysplastic Bone Marrow apremilast ...
Current Search: myelodysplastic: 23, bone: 3497, marrow: 1095, apremilast: 2, pharmion: 17, vidaza: 48, revlimid: 84, psor: 2, revlimidr: 16 ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Pharmion - Profile
Pharmion is a global specialty pharmaceutical company that is dedicated to the ... Pharmaceutical Business Review: Oct 31 2008 8:16AM Matching: pharmion ...
http://www.bioportfolio.com/biocorporate/8302-Pharmion.pdf...
|
Biotechnology News Myelodysplastic Bone Marrow alkeran. vidaza ...
Current Search: myelodysplastic: 23, bone: 3497, marrow: 1095, alkeran: 2, vidaza: 48, thalomid: 17, pharmion: 17, revlimid: 84, celg: 73 ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Biocorporate Search Boulder
Pharmion is a global specialty pharmaceutical company that is dedicated to the hematology and oncology communities. With proven development and regulatory ...
http://www.bioportfolio.com/biocorporate/search/city/Boulder...
|
Biotechnology News Sleep Initiation Maintenance apremilast ...
Current Search: sleep: 1595, initiation: 194, maintenance: 115, apremilast: 2, pharmion: 17, vidaza: 48, 2290: 3, revlimid: 86, psor: 2 ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
Results from other life science and pharmaceutical sites:
Pharmion Corporation
A global pharmaceutical company designed to acquire or license, develop, and commercialize acute care and specialty pharmaceutical products.
http://www.pharmion.com/...
|
Pharmion Corporation and MethylGene Announce U.S. Orphan Drug ...
14 /PRNewswire-FirstCall/ -- Pharmion Corporation and MethylGene Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the
...
http://www.biospace.com/news_story.aspx?NewsEntityId=86116...
|
EMEA Accepts for Review Thalidomide Pharmion(R) Marketing ...
"We believe that these data clearly demonstrate the value Thalidomide Pharmion provides patients with untreated multiple myeloma," said Patrick J. Mahaffy, ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Pharmion Corporation and MethylGene Present Favorable Clinical ...
11 Dec 2007 ... 10 /PRNewswire-FirstCall/ -- Pharmion Corporation and MethylGene Inc today announced maturing data from the Phase 1/2 study investigating ...
http://www.biospace.com/news_story.aspx?NewsEntityId=80118...
|
BioPortfolio - Pharmion - Profile
Pharmion is a global specialty pharmaceutical company that is dedicated to the ... Pharmaceutical Business Review: Oct 31 2008 8:16AM Matching: pharmion ...
http://www.bioportfolio.com/biocorporate/8302-Pharmion.pdf...
|
Pharmion Corporation Initiates Pivotal Phase 3 Study of Amrubicin ...
BOULDER, Colo., Oct. 17 /PRNewswire-FirstCall/ -- Pharmion Corporation today announced the initiation of an international pivotal Phase 3 clinical trial ...
http://www.biospace.com/news_story.aspx?NewsEntityId=73707...
|
Pharmion Corporation Reports Net Sales of $65.8 Million for Q2 2007
"We are pleased with our financial results for the quarter, achieving record sales in total and for Vidaza," said Patrick J. Mahaffy, Pharmion's president
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
GPC-Biotech
“We are currently discussing with our partners, Pharmion and Yakult, plans for the future development of satraplatin. I would like to warmly thank and ...
http://www.gpc-biotech.com/en/news_media/press_releases/2007...
|
Schering Enters Into Agreement With Pharmion Regarding Refludan(R ...
The agreement allows Pharmion to market Refludan(R) in the initial indication of Heparin Induced Thrombocytopenia (HIT). Schering is committed to actively ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
GPC-Biotech
21 May 2007 ... GPC Biotech has a co-development and license agreement with Pharmion GmbH, a wholly owned subsidiary of Pharmion Corporation, ...
http://www.gpc-biotech.com/en/news_media/press_releases/2007...
|
|
